Robust Sampling of Defective Pathways in Alzheimer’s Disease. Implications in Drug Repositioning
We present the analysis of the defective genetic pathways of the Late-Onset Alzheimer’s Disease (LOAD) compared to the Mild Cognitive Impairment (MCI) and Healthy Controls (HC) using different sampling methodologies. These algorithms sample the uncertainty space that is intrinsic to any kind of high...
Main Authors: | Juan Luis Fernández-Martínez, Óscar Álvarez-Machancoses, Enrique J. de Andrés-Galiana, Guillermina Bea, Andrzej Kloczkowski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/10/3594 |
Similar Items
-
Development of Pigmentation-Regulating Agents by Drug Repositioning
by: Seo-Mi-Gon Jeong, et al.
Published: (2021-04-01) -
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers
by: Kamal Ahmed, et al.
Published: (2016-07-01) -
Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
by: Clive Ballard, et al.
Published: (2013-10-01) -
Individualized Drug Repositioning For Rheumatoid Arthritis Using Weighted Kolmogorov–Smirnov Algorithm
by: Hu RY, et al.
Published: (2019-12-01) -
A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
by: Soo Youn Lee, et al.
Published: (2020-01-01)